Sat.May 03, 2025

article thumbnail

What You Should Know About ALS, Also Known as Lou Gehrig’s Disease

Drugs.com

SATURDAY, May 3, 2025 Amyotrophic lateral sclerosis (ALS) known as Lou Gehrigs Disease based on the iconic 1930s New York Yankee baseball player is a progressive neurodegenerative disease that affects thousands of Americans every year. ALS re.

Disease 238
article thumbnail

Osthole Induces Hepatic Stellate Cell Ferroptosis to Alleviate Liver Fibrosis by Inhibiting the Y‐Box Binding Protein 1‐Wnt/β‐Catenin Axis Through Downregulating Myocyte Enhancer Factor 2A

Chemical Biology and Drug Design

Osthole reduced YBX1 transcription by inhibiting MEF2A expression, thereby inactivating Wnt/-catenin signaling and inducing ferroptosis to alleviate liver fibrosis. ABSTRACT Liver fibrosis is pathologically associated with ferroptosis. Osthole (OST) has good therapeutic effects on liver fibrosis. Our study sought to investigate the pharmacological effects of OST on ferroptosis in hepatic stellate cells (HSCs) during the development of liver fibrosis and define the mechanisms involved.

Treatment 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Computational Design of a Bicyclic Peptide Inhibitor Targeting the ICOS/ICOS‐L Protein–Protein Interaction

Chemical Biology and Drug Design

Design of ICOS/ICOS-L cyclic peptide inhibitor based on mimicking key interactions of ICOS-L with ICOS. ABSTRACT The interaction between the inducible T-cell costimulatory molecule (ICOS) and its ligand (ICOS-L) is a critical pathway in T-cell activation and immune regulation. We computationally designed a bicyclic peptide (CP5) that inhibits the ICOS/ICOS-L proteinprotein interaction (PPI).

article thumbnail

The Transfer of USP25 by Exosomes of Adipose Tissue‐Derived Mesenchymal Stem Cells Ameliorates Diabetic Nephropathy Through Stabilizing SMAD7 Expression

Chemical Biology and Drug Design

ADSCs-EV transferred USP25 deubiquitinates and stabilizes SMAD7 expression in podocytes, thereby attenuating T2DM-induced kidney injury and podocyte apoptosis and inflammation. ABSTRACT Adipose tissue-derived mesenchymal stem cells (ADSCs) are identified to be potential therapeutic candidates for diabetic nephropathy (DN) through secreting exosomes (Exos).

Research 100
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!